HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.

Jacob Kinggaard Lilja-Fischer Morten Horsholt Kristensen Pernille Lassen Torben Steiniche Trine Tramm Magnus Stougaard Christian Maare Jorgen Johansen Hanne Primdahl Claus Andrup Kristensen Maria Andersen Jesper Grau Eriksen Jens Overgaard

Published in: Acta oncologica (Stockholm, Sweden) (2023)

In the present study, HPV DNA testing or typing in a Danish OPSCC cohort did not add additional information to p16 IHC, the most widely used and accepted prognostic indicator.

Keyphrases

squamous cell carcinoma
healthcare
health information
cell free
rectal cancer
genetic diversity